Generation of duck cell lines

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9260694
APP PUB NO 20140154741A1
SERIAL NO

14069423

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to the development and manufacturing of viral vaccines. In particular, the invention relates to the field of industrial production of viral vectors and vaccines, more in particular to the use of avian embryonic stem cells, preferably the EBx® cell line derived from duck embryonic stem cells, for the production of viral vectors and viruses. The invention is particularly useful for the industrial production of viral vaccines to prevent viral infection of humans and animals.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • VALNEVA;VIVALIS SA

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Esnault, Magali Basse-Indre, FR 4 14
Guehenneux, Fabienne Orvault, FR 15 116
Mehtali, Majid Coueron, FR 47 448
Moreau, Karine Nantes, FR 5 14

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 16, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00